Enhanced anti‐Aß immunotherapies using nanobodies in an AD mouse model
This study explores innovative passive immunotherapy strategies targeting Aβ, with potential to advance AD treatment and deepen understanding of the disease's pathophysiology.
Authors
- Pierre Benjamin Lafaye
- Sylvie Bay (ORCID: https://orcid.org/0000-0002-3538-2163)
- Françoise Piguet
- Amandine Géraudie
- Benoît Delatour
- Jean David Randrianaly
- Alexandre Florent Trotier
- Sylvie Jacquot
- Alzheimer's and Prion diseases
Institutions
- Centre National de la Recherche Scientifique (FR)
- Allen Institute for Brain Science (US)
- Inserm (FR)
- Institut Pasteur (FR)
- Sorbonne Université (FR)
- Institut de Psychiatrie et Neurosciences de Paris (FR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_103908
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00